Huijuan Mao

2.0k citations
97 papers · 1.4k indexed · h-index 19
Topics
Acute Kidney Injury Research (19 papers)Parathyroid Disorders and Treatments (15 papers)Renal Diseases and Glomerulopathies (14 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Huijuan Mao

88 papers receiving 1.3k citations

Peers

Huijuan Mao
Comparison fields: 5 of 101
  • Nephrology 749
  • Surgery 364
  • Cardiology and Cardiovascular Medicine 262
  • Molecular Biology 212
  • Epidemiology 181
Replace Mark A.J. Devonald with:
Mark A.J. Devonald United Kingdom
Xiaoqiang Ding China
Belda Dursun Türkiye
Ki Ryang Na South Korea
Kousuke Negishi Japan
Prabhleen Singh United States
Alessandra Brocca Italy
Vaidyanathapuram S. Balakrishnan United States
Yoon-Goo Kim South Korea
Jianzhou Zou China
Huijuan Mao relative to Mark A.J. Devonald United Kingdom Mark A.J. Devonald's profile →
Citations per field
00.5×1.5×2.1×
Mark A.J. Devonald · 1×
Citations per year

Countries citing papers authored by Huijuan Mao

Since Specialization
Citations

This map shows the geographic impact of Huijuan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijuan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijuan Mao more than expected).

Fields of papers citing papers by Huijuan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huijuan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijuan Mao. The network helps show where Huijuan Mao may publish in the future.

Co-authorship network of co-authors of Huijuan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Huijuan Mao. A scholar is included among the top collaborators of Huijuan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huijuan Mao. Huijuan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 0
5 2
6 2
7 0
8 1
9 0
10 3
11 5
12 11
13 2
14 7
15 32
16 52
17 21
18 37
19 2
20 186

About Huijuan Mao

Huijuan Mao is a scholar working on Nephrology, Microbiology and Critical Care and Intensive Care Medicine, having authored 97 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (19 papers), Parathyroid Disorders and Treatments (15 papers) and Renal Diseases and Glomerulopathies (14 papers). The work is most often cited by research in Nephrology (749 citations), Critical Care and Intensive Care Medicine (136 citations) and Emergency Medicine (172 citations). Huijuan Mao has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Changying Xing, Bo Zhang, Claudio Ronco, Ningning Wang, Xiangbao Yu, Yanggang Yuan, Nevin Katz, Ningning Wang, Buyun Wu and Lin Wu. Their work appears in journals such as PLoS ONE, Scientific Reports and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026